T2 Biosystems Reports 50 Percent Product Revenue Growth in Prelim Q4 Results | GenomeWeb

NEW YORK (GenomeWeb) – T2 Biosystems today preliminarily reported a 50 percent increase year over year in product revenue growth for the fourth quarter of 2016.

The Lexington, Massachusetts-based diagnostics firm attributed the growth to an increase in T2Candida Panel sales associated with increased patient testing across the installed base. The firm also secured eight new contracts covering 18 hospitals in the US and Europe and has increased its worldwide installed base to include 143 hospitals with access to T2Dx Instruments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.